As more trials continue to take place testing GLP-1 drugs for the treatment of other indications, including heart failure, sleep apnea, advanced fatty liver disease, and cardiovascular events, more information is likely to come to light about the potential of these drugs, which, right now, seems to be endless
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight
Without thoughtful benefit strategies, affordability challenges will continue to grow, Faust said
Per one nationally representative survey of about 2,000 adults conducted by researchers at the Kinsey Institute at Indiana University Bloomington, which studies relationships and sexuality, found that about 16% of respondents felt their libido dropped and about 12% reported worse sexual function
You will learn average pricing by dosage, how clinic and mobile NAD IV therapy compare, what actually drives the cost, how NAD injections differ and what to expect during treatment
Pabaus claims management software and measurements tracking tools give weight management clinics the infrastructure to document BMI, record comorbidities, and assign E66.01 correctly at every visit
